Clinical Trial

Ursodeoxycholic Acid in Patients With NAFLD - Clinical Observation

Study acronym: URSO
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 17, 2025 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Patients with NAFLD indicated for ursodeoxycholic acid treatment ("by SPC: cholestatic hepatitis") will be offered an observational study. Examinations will be performed before the treatment and after 6month period. Laboratory parameters, non-invasive indices, liver elastography, cardiovascular parameters and liver MR spectroscopy will be performed.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-02-16; most recent amendment 2025-03-14.
Status change: Recruiting → Active, Not Recruiting 2025-03-14
Status change: Not Yet Recruiting → Recruiting 2022-08-02
Trial Details
NCT Number NCT05256979
Lead Sponsor General University Hospital, Prague
Conditions Non-Alcoholic Fatty Liver Disease
Enrollment 20 participants
Start Date 2022-07-02
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-17